Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bray

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Maternal and Child Health Journal|December 2, 2022
Using a LIFE Framework to Develop MCH LeadersSharon Milberger, Ke Zhang, Michael Bray, et al.
Maternal and Child Health Journal|October 27, 2023
Developing Workforce Skills and Capacity in Telehealth: What LEND Trainees Need to KnowMichael Bray, Jane Turner, Sean Jones, et al.
Journal of Gerontological Social Work|August 11, 2022
Evaluating the Benefits of a Family Support Program on the Health and Well-Being of Aging Family Caregivers of Adults with Intellectual and Developmental DisabilitiesSharon Milberger, Christina Marsack-Topolewski, Elizabeth Janks, et al.
Analytical and Bioanalytical Chemistry|September 1, 2004
Development of a fluorescent microplate assay for determining cyanovirin-N levels in plasmaScott D Bringans, Barry R O'Keefe, Michael Bray, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 16, 2022
The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment TrialsMichael Bray, Yoonhoo Chang, Timothy B Baker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 27, 2020
Participatory Design of a Personalized Genetic Risk Tool to Promote Behavioral HealthAlex T Ramsey, Michael Bray, Penina Acayo Laker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 22, 2020
Proof of Concept of a Personalized Genetic Risk Tool to Promote Smoking Cessation: High Acceptability and Reduced Cigarette SmokingAlex T Ramsey, Jessica L Bourdon, Michael Bray, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Functional Evidence for Substantia Nigra Pars Reticulata Involvement in Auditory Verbal Hallucinations in Treatment-Resistant SchizophreniaAnruo Shen, Yousef Salimpour, Ankur Butala, et al.
Schizophrenia (Heidelberg, Germany)|January 21, 2026
Substantia nigra pars reticulata involvement in auditory hallucinations of treatment-resistant schizophrenia: a deep brain stimulation case reportAnruo Shen, Yousef Salimpour, Ankur Butala, et al.
Clinical Pharmacology and Therapeutics|July 1, 2020
Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled TrialLi-Shiun Chen, Timothy B Baker, J Philip Miller, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Maternal and Child Health Journal|December 2, 2022
Using a LIFE Framework to Develop MCH LeadersSharon Milberger, Ke Zhang, Michael Bray, et al.
Maternal and Child Health Journal|October 27, 2023
Developing Workforce Skills and Capacity in Telehealth: What LEND Trainees Need to KnowMichael Bray, Jane Turner, Sean Jones, et al.
Journal of Gerontological Social Work|August 11, 2022
Evaluating the Benefits of a Family Support Program on the Health and Well-Being of Aging Family Caregivers of Adults with Intellectual and Developmental DisabilitiesSharon Milberger, Christina Marsack-Topolewski, Elizabeth Janks, et al.
Analytical and Bioanalytical Chemistry|September 1, 2004
Development of a fluorescent microplate assay for determining cyanovirin-N levels in plasmaScott D Bringans, Barry R O'Keefe, Michael Bray, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|February 16, 2022
The Promise of Polygenic Risk Prediction in Smoking Cessation: Evidence From Two Treatment TrialsMichael Bray, Yoonhoo Chang, Timothy B Baker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 27, 2020
Participatory Design of a Personalized Genetic Risk Tool to Promote Behavioral HealthAlex T Ramsey, Michael Bray, Penina Acayo Laker, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 22, 2020
Proof of Concept of a Personalized Genetic Risk Tool to Promote Smoking Cessation: High Acceptability and Reduced Cigarette SmokingAlex T Ramsey, Jessica L Bourdon, Michael Bray, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Functional Evidence for Substantia Nigra Pars Reticulata Involvement in Auditory Verbal Hallucinations in Treatment-Resistant SchizophreniaAnruo Shen, Yousef Salimpour, Ankur Butala, et al.
Schizophrenia (Heidelberg, Germany)|January 21, 2026
Substantia nigra pars reticulata involvement in auditory hallucinations of treatment-resistant schizophrenia: a deep brain stimulation case reportAnruo Shen, Yousef Salimpour, Ankur Butala, et al.
Clinical Pharmacology and Therapeutics|July 1, 2020
Genetic Variant in CHRNA5 and Response to Varenicline and Combination Nicotine Replacement in a Randomized Placebo-Controlled TrialLi-Shiun Chen, Timothy B Baker, J Philip Miller, et al.
Pageof 2